Pure Global Cannabis Awarded Health Canada Sales License
15 January 2019 - 1:14AM
InvestorsHub NewsWire
Pure Global Cannabis Awarded Health
Canada Sales License
TORONTO , Jan. 11, 2019 /CNW/ - Pure Global Cannabis Inc.
(TSX.V:PURE; OTC: PRCNF; FRA:1QS) (the "Company"
or "Pure Global") an integrated, growth-oriented life sciences and
consumer products cannabis company, through its subsidiary
PureSinse Inc. ("PureSinse"), is excited to announce that Health
Canada has issued PureSinse a Sales License under the Cannabis
Act.
Eligible and pre-registered Canadian
medical patients can soon select from two dozen premium cannabis
products offered by PureSinse, via its newly launched eCommerce
website at PureSinse.com. The Company is committed to supporting
medical cannabis patients by emphasizing the quality of and access
to the products they need. The Company anticipates growing to 70
SKUs (stock-keeping units) by mid-2019, including adding extracted
oil products, and vape pens.
PureSinse continues to demonstrate
commitment to the medical community by leading one of the largest
real-world evidence-based clinical studies in conjunction with the
Appletree Medical Group and one of the largest Clinical Research
Organizations in the world. The clinical data, which will be
collected from thousands of patients, will provide necessary data
points for guidance in the therapeutic benefits of specific
cannabis strains for commonly reported medical symptoms. This
evidence will guide PureSinse's future pharmaceutical product and
consumer product development plans and provide the medical
community with published peer reviewed observational data on the
efficacy of medical cannabis for a range of conditions.
As part of the Sales Licence, the
Company can also sell products into the adult-legal consumer market
through provincially licensed retailers, for which it is launching
uniquely curated lines of consumer products tailored to specific
market segments.
"This is a significant milestone for us and something we
have been vigorously preparing for over the last several months,"
said Malay Panchal, CEO of Pure Global. "We feel the medical
community has been hugely underserviced with poor patient and
physician education, and product offerings, areas we hope to be
trail blazers in and make a significant contribution to in 2019,"
added Mr. Panchal.
About Pure Global
Cannabis
Pure Global Cannabis Inc. (TSX.V:PURE; OTC:PRCNF; FRA:1QS) is an
innovation-based cannabis Company led by experienced pharma,
biotechnology, horticultural, and consumer packaged goods (CPG)
experts. The Company's wholly owned subsidiary, PureSinse Inc., is
a licensed producer under the Cannabis Act. The
Company's Brampton campus houses facilities for
vertically farmed cultivation, R&D, extraction, manufacturing,
and distribution. PURE will produce branded and white-labeled
cannabis products for the medical, pharmaceutical, wellness, health
& beauty, natural health, food & beverage, and recreational
legal markets with uniquely formulated and purified concentrates.
The Company is using the Canadian market as a springboard to
develop and manufacture GMP-compliant cannabis products for
international sale and distribution with a goal to become one of
the most trusted premium international cannabis brands.
To
register to Pure Global's mailing list, please
visit www.pureglobal.com. Follow @pureglobalcanna
on Twitter and Facebook and @pureglobalcannabis
on Instagram.
FORWARD-LOOKING
STATEMENTS
This news release contains certain forward-looking statements,
including, but not limited to, statements about Pure Global's
future plans and intentions. Wherever possible, words such as
"may", "will", "should", "could", "expect", "plan", "intend",
"anticipate", "believe", "estimate", "predict" or "potential" or
the negative or other variations of these words, or similar words
or phrases, have been used to identify these forward-looking
statements. These statements reflect management's current beliefs
and are based on information currently available to management as
at the date hereof.
Forward-looking statements involve significant risk, uncertainties
and assumptions. Many factors could cause actual results,
performance or achievements to differ materially from the results
discussed or implied in the forward-looking statements. These
factors should be considered carefully and readers should not place
undue reliance on the forward-looking statements. Although the
forward-looking statements contained in this news release are based
upon what management believes to be reasonable assumptions, Pure
Global cannot assure readers that actual results will be consistent
with these forward-looking statements. These forward-looking
statements are made as of the date of this news release, and Pure
Global assumes no obligation to update or revise them to reflect
new events or circumstances, except as required by law.
Neither the TSX Venture Exchange
nor its Regulation Services Provider (as that term is defined in
the policies of the TSXV) accepts responsibility for the adequacy
or accuracy of this release.
To
register to Pure Global's mailing list, please visit
www.pureglobal.com. Follow @pureglobalcanna on Twitter and Facebook
and @pureglobalcannabis on Instagram.
SOURCE Pure Global Cannabis Inc.
Pure Global Cannabis (TSXV:PURE)
Historical Stock Chart
From Oct 2024 to Nov 2024
Pure Global Cannabis (TSXV:PURE)
Historical Stock Chart
From Nov 2023 to Nov 2024
